Pre-Vaccination Human Papillomavirus Genotypes and HPV16 Variants among Women Aged 25 Years or Less with Cervical Cancer

Background: In 2007, Australia introduced a national human papillomavirus (HPV) vaccination program. In 2017, the onset of cervical screening changed from 18 to 25 years of age, utilising human papillomavirus (HPV) nucleic acid testing. The objective of the study is to describe the HPV genotypes and...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yasmin L. Jayasinghe, Sepehr N. Tabrizi, Matthew Stevens, Trishe Y-M. Leong, Jan Pyman, Sonia R. Grover, Suzanne M. Garland, the Early-Onset Cervical Cancer (EOCC) Study Group
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2023-03-01
coleção:	Pathogens
Assuntos:	cervical cancer young women human papillomavirus genotyping HPV vaccine HPV16 variants
Acesso em linha:	https://www.mdpi.com/2076-0817/12/3/451
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!